ATE335496T1 - Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung - Google Patents

Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung

Info

Publication number: ATE335496T1
Authority: AT; Austria
Prior art keywords: analogues; adhesion formation; angiotensin; aii; limiting
Prior art date: 1999-03-23

Application number

AT00918281T

Other languages

English (en)

Inventor

Kathleen Rodgers

Gere Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-23

Filing date

2000-03-22

Publication date

2006-09-15

2000-03-22 Application filed by Univ Southern California filed Critical Univ Southern California

2006-09-15 Application granted granted Critical

2006-09-15 Publication of ATE335496T1 publication Critical patent/ATE335496T1/de

Links

230000015572 biosynthetic process Effects 0.000 title abstract 2
231100000241 scar Toxicity 0.000 title abstract 2
102000005862 Angiotensin II Human genes 0.000 title 1
101800000733 Angiotensin-2 Proteins 0.000 title 1
208000032544 Cicatrix Diseases 0.000 title 1
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 title 1
229950006323 angiotensin ii Drugs 0.000 title 1
230000037387 scars Effects 0.000 title 1
239000012634 fragment Substances 0.000 abstract 2
239000005541 ACE inhibitor Substances 0.000 abstract 1
102000004881 Angiotensinogen Human genes 0.000 abstract 1
108090001067 Angiotensinogen Proteins 0.000 abstract 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000018 receptor agonist Substances 0.000 abstract 1
229940044601 receptor agonist Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

AT00918281T 1999-03-23 2000-03-22 Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung ATE335496T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12570799P	1999-03-23	1999-03-23
US13954199P	1999-06-16	1999-06-16

Publications (1)

Publication Number	Publication Date
ATE335496T1 true ATE335496T1 (de)	2006-09-15

Family

ID=26823846

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00918281T ATE335496T1 (de)	1999-03-23	2000-03-22	Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung

Country Status (8)

Country	Link
EP (1)	EP1165099B1 (de)
JP (1)	JP3745624B2 (de)
AT (1)	ATE335496T1 (de)
AU (1)	AU756156B2 (de)
CA (1)	CA2367107C (de)
DE (1)	DE60029937T2 (de)
ES (1)	ES2267513T3 (de)
WO (1)	WO2000056345A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
WO2002096883A1 (en)	2001-05-31	2002-12-05	Vicore Pharma Ab	Tricyclic compounds useful as angiotensin ii agonists
AU2005274574B2 (en)	2004-08-18	2011-03-17	Ace Aps	Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
CA2623471C (en) *	2004-09-23	2018-02-13	Arc Pharmaceuticals, Inc.	Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
SG10201502348VA (en) *	2010-03-26	2015-05-28	Univ Southern California	Methods for treating combined radiation and thermal injury
EP2455388A1 (de)	2010-11-23	2012-05-23	LanthioPep B.V.	Neuartige Rezeptoragonisten von Angiotensin des Typs 2 (AT2) und Verwendungen dafür
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
EP3655008A4 (de) *	2017-07-17	2021-04-07	Monash University	Angiotensin-rezeptoragonisten und verwendungen davon
JP2022542437A (ja)	2019-08-02	2022-10-03	ランティオペプベスローテンヴェンノーツハップ	癌の処置に用いるアンジオテンシン２型（ａｔ２）受容体アゴニスト

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU697504B2 (en) *	1993-09-24	1998-10-08	University Of Southern California	Use of angiotensin II analogs in tissue repair
AU6650098A (en) *	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries

2000
- 2000-03-22 AT AT00918281T patent/ATE335496T1/de not_active IP Right Cessation
- 2000-03-22 JP JP2000606249A patent/JP3745624B2/ja not_active Expired - Fee Related
- 2000-03-22 EP EP00918281A patent/EP1165099B1/de not_active Expired - Lifetime
- 2000-03-22 CA CA002367107A patent/CA2367107C/en not_active Expired - Fee Related
- 2000-03-22 DE DE60029937T patent/DE60029937T2/de not_active Expired - Lifetime
- 2000-03-22 WO PCT/US2000/007669 patent/WO2000056345A2/en not_active Ceased
- 2000-03-22 AU AU39117/00A patent/AU756156B2/en not_active Ceased
- 2000-03-22 ES ES00918281T patent/ES2267513T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60029937D1 (de)	2006-09-21
JP2002539267A (ja)	2002-11-19
CA2367107C (en)	2003-10-14
WO2000056345A3 (en)	2001-01-11
AU3911700A (en)	2000-10-09
ES2267513T3 (es)	2007-03-16
WO2000056345A9 (en)	2002-06-27
JP3745624B2 (ja)	2006-02-15
EP1165099B1 (de)	2006-08-09
AU756156B2 (en)	2003-01-02
CA2367107A1 (en)	2000-09-28
DE60029937T2 (de)	2007-09-06
WO2000056345A2 (en)	2000-09-28
EP1165099A2 (de)	2002-01-02

Similar Documents

Publication	Publication Date	Title
WO2000053211A3 (en)	2001-01-25	Method of promoting myocyte proliferation and myocardial tissue repair
BR0112292A (pt)	2003-06-24	Composto, composição farmacêutica, método para tratar ou prevenir disfunções tromboembólicas e uso de um composto
ID26984A (id)	2001-02-22	Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
MY138289A (en)	2009-05-29	Pharmaceutical compositions
WO2000071507A3 (en)	2001-11-15	INHIBITORS OF FACTOR Xa
ES2619332T3 (es)	2017-06-26	Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma
ATE314062T1 (de)	2006-01-15	Zusammensetzungen zur abgabe von cortisolantagonisten
ATE410996T1 (de)	2008-10-15	Methoden zur behandlung von nägeln
ATE335496T1 (de)	2006-09-15	Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
GB2419529A (en)	2006-05-03	Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
MXPA04000586A (es)	2004-04-20	Combinacion de un atagonista del receptor de aldosterona con un inhibidor de la hmg coa reductasa.
SE0202598D0 (sv)	2002-09-02	Alpha-7 Nicotinic receptor agonists and statins in combination
DE69924715D1 (de)	2005-05-19	Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
BRPI0412919A (pt)	2006-09-26	combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
YU13301A (sh)	2005-06-10	Muskarinski agonisti i antagonisti
AU1023497A (en)	1997-06-27	Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
ES2088128T3 (es)	1996-08-01	Aminosulfonilureas inhibidoras de acat.
CA2323237A1 (en)	1999-09-16	Improved radiation therapy methods
WO2004009773A3 (en)	2004-11-11	Methods and compositions for activating or inhibiting vegf-d and vegf-c
IL144199A0 (en)	2002-05-23	Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
EA200601592A1 (ru)	2006-12-29	Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
WO2001055176A3 (en)	2002-07-25	Methods for inhibiting smooth muscle cell proliferation
WO2002006308A3 (en)	2003-02-27	Methods for promoting dendritic cell proliferation or differentiation
WO2001044270A3 (en)	2002-10-31	Methods for treating and preventing diabetic complications by use of angiotensin-related peptides
AU2003251729A1 (en)	2004-01-19	Use of antibodies against flt-1 for the treatment of osteoporosis

Legal Events

Date	Code	Title	Description
2007-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties